CClinicalTrials.gg
Sign In
Not yet recruitingNCT07271134Updated Dec 16, 2025

Short-term Observation on the Clinical Application Effect of Astra Tech Implant EV Short Implants for Maxillary Sinus Elevation

An interventional study of short implants (L=6.3mm) and short implants (L=8mm) in Missing Teeth, sponsored by Linhu Wang. Not yet recruiting at 1 site in China. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-16.

Sponsored by Linhu Wang · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Not applicable
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Short-term comparison of clinical application effects of Astra OsseoSpeed EV short implants and conventional implants for maxillary sinus elevation

Read the detailed description
  1. If the survival rate, marginal bone resorption , complications and patient satisfaction of the short implant group are comparable or better than those of the conventional implant group, then short implants can be regarded as an effective treatment option for insufficient alveolar bone in the posterior teeth area. Thus, in clinical practice, the investigators can utilize short implants combined with transcrestal sinus floor elevation, or even implant short implants to help patients with certain insufficient maxillary bone complete implant restoration without resorting to more complex, costly and more invasive external elevation surgery to increase the length of posterior teeth implants in the maxillary region.
  2. If it is found that the short implant group has a higher incidence of complications or a lower long-term survival rate, further exploration of its indications and optimization of surgical strategies is required.
02

Conditions studied

  • Missing Teeth

Browse trials for

Keywords

  • Short implant
  • Maxillary sinus floor elevation
03

In context

Anodontia

85 studies on the registry are indexed under Anodontia; 22 are open to participants now.

This study's planned enrollment of 36 is above the median of 30 across 61 interventional studies indexed under Anodontia.

Browse Anodontia studies →

Lead sponsor

This is the only study on the registry with Linhu Wang as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patients aged over 18 years old with at least one area of the posterior dental arch having insufficient alveolar bone height (3-6 mm)
  • Patients are in good health and have no major systemic diseases such as diabetes or cardiovascular diseases, and no maxillary sinus lesions
  • They are willing to undergo implant restoration treatment and can complete at least 3-year follow-up.

Exclusion criteria

Exclusion Criteria:

  • horizontal bone deficiency alveolar ridges,bone defects caused by tumor resection
  • excessive tobacco use (more than 10 cigarettes per day)
  • severe liver and kidney diseases
  • history of radiotherapy and chemotherapy in the head and neck region
  • uncontrolled diabetes
  • active periodontal disease
  • oral mucosal diseases in the treatment area or poor oral hygiene,
  • PI > 70%
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    transcrestal sinus floor elevation

    Device: short implants (L=6.3mm) · Procedure: short implants (L=8mm) · Device: conventional implants (L=9mm)

Interventions

  • Deviceshort implants (L=6.3mm)

    Short-term clinical outcome of Astra OsseoSpeed EV short implants (L=6.3mm) for transcrestal sinus floor elevation

  • Procedureshort implants (L=8mm)

    Short-term clinical outcome of Astra OsseoSpeed EV short implants (L=8mm) for transcrestal sinus floor elevation

  • Deviceconventional implants (L=9mm)

    conventional implants (L=9mm) in the posterior maxillary region for dental restoration

06

What researchers measure

Primary outcomes

  1. Various complications

    the rate of Implant survival, swelling, pain, etc.

    Time frame: From having a tooth implant to one year after wearing the dentures

Secondary outcomes

  1. marginal bone resorption

    Measure the changes in the bone height around the implant

    Time frame: one year

Other outcomes

  1. Patient satisfaction

    Very satisfied, satisfied, dissatisfied, the rate of dissatisfaction, etc.

    Time frame: From having a tooth implant to one year after wearing the dentures

07

Study locations

1 site
  • No. 26, Shengli Street, Jiang'an District, Wuhan City, Hubei Province, China
    Wuhan, Hubei 422202, China
08

References and documents

Individual participant data

Plan to share: Yes — Methods and Results

Supporting information: Study protocol, Icf, Csr

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 16, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07271134
Lead sponsor
Linhu Wang
Collaborators
Dentsply Sirona Implants and Consumables
Responsible party
Linhu Wang (Medical professor, Wuhan Central Hospital) — Sponsor-investigator
First posted
Dec 9, 2025
Start date
Dec 10, 2025 (estimated)
Primary completion
Jun 30, 2027 (estimated)
Completion
Jul 30, 2028 (estimated)
Last update
Dec 16, 2025

Study contacts

lin hu Wang, Doctoral
Contact
316036445@qq.com
+8618086060633

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Anodontia→

Start the discussion